Graves ophthalmopathy is a disfiguring and often incapacitating disease that is difficult to treat. A meta-analysis has compared the efficacy and tolerability of available treatment modalities and shows, among other findings, that intravenous pulse corticosteroid therapy is the most efficacious treatment when immunosuppression is indicated.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Stiebel-Kalish, H. et al. Treatment modalities for Graves' ophthalmopathy—systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 94, 2708–2716 (2009).
Mourits, M. P., Prummel, M. F., Wiersinga, W. M. & Koornneef, L. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy. Clin. Endocrinol. 47, 9–14 (1997).
Dickinson, A. J. & Perros, P. Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin. Endocrinol. (Oxf.) 55, 283–303 (2001).
van Geest, R. J. et al. Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study. Eur. J. Endocrinol. 158, 229–237 (2008).
Le Moli, R. et al. Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy. Thyroid 17, 357–362 (2007).
Bartalena, L. et al. Consensus statement of the European Group on Graves' Orbitopathy (EUGOGO) on management of GO. Eur. J. Endocrinol. 158, 273–285 (2008).
Bradley, E. A. et al. Orbital irradiation for Graves' ophthalmopathy: a report by the American Academy of Ophthalmology. Ophthalmology 115, 398–409 (2008).
Wei, R. L., Cheng, J. W. & Cai, J. P. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence. Ophthalmologica 222, 27–31 (2008).
Estcourt, S., Hickey, J., Perros, P., Dayan, C. & Vaidya, B. The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey. Eur. J. Endocrinol. 161, 483–487 (2009).
Wiersinga, W. M. & Bartalena, L. Epidemiology and prevention of Graves' ophthalmopathy. Thyroid 12, 855–860 (2002).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Wiersinga, W. Evidence-based treatment of Graves ophthalmopathy. Nat Rev Endocrinol 5, 653–654 (2009). https://doi.org/10.1038/nrendo.2009.222
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2009.222
